[go: up one dir, main page]

UY30423A1 - Derivados de cianoquinolina, su preparacion, uso y medicamentos que lo comprenden. - Google Patents

Derivados de cianoquinolina, su preparacion, uso y medicamentos que lo comprenden.

Info

Publication number
UY30423A1
UY30423A1 UY30423A UY30423A UY30423A1 UY 30423 A1 UY30423 A1 UY 30423A1 UY 30423 A UY30423 A UY 30423A UY 30423 A UY30423 A UY 30423A UY 30423 A1 UY30423 A1 UY 30423A1
Authority
UY
Uruguay
Prior art keywords
preparation
cianoquinoline
medicines
derivatives
understand
Prior art date
Application number
UY30423A
Other languages
English (en)
Inventor
Judith Guenther
Wolfgang Schwede
Olaf Prien
Knut Eis
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of UY30423A1 publication Critical patent/UY30423A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Derivado de quinolina que responde a la formula general (A): en donde R1, R2, X, Y y Z tienen los valores que se indican en la memoria descriptiva y las reivindicaciones, uso de los compuestos de la formula general (A) para el tratamiento de diversos trastornos, y preparacion de compuestos de formula general (A).
UY30423A 2006-06-21 2007-06-20 Derivados de cianoquinolina, su preparacion, uso y medicamentos que lo comprenden. UY30423A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006029445A DE102006029445A1 (de) 2006-06-21 2006-06-21 Neue 3-Cyano-chinoline als Kinase-Inhibitoren

Publications (1)

Publication Number Publication Date
UY30423A1 true UY30423A1 (es) 2008-01-31

Family

ID=38595973

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30423A UY30423A1 (es) 2006-06-21 2007-06-20 Derivados de cianoquinolina, su preparacion, uso y medicamentos que lo comprenden.

Country Status (10)

Country Link
US (1) US7598263B2 (es)
EP (1) EP2035433A1 (es)
JP (1) JP2009542584A (es)
AR (1) AR061535A1 (es)
CA (1) CA2654234A1 (es)
DE (1) DE102006029445A1 (es)
PE (1) PE20080340A1 (es)
TW (1) TW200808700A (es)
UY (1) UY30423A1 (es)
WO (1) WO2007147576A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2023367084A1 (en) * 2022-10-26 2025-04-03 The Board Of Regents Of The University Of Texas System Small molecular weight chemical compound to antagonize eph-ephrin tetramerization and inhibit bidirectional signaling

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0081836B1 (en) * 1981-12-14 1986-03-05 Norwich Eaton Pharmaceuticals, Inc. Use of the compound 9-(p-(n-methylacetamido)anilino)-7-methyl-1h-imidazo(4,5-f)quinoline hydrochloride (i) as antitumor agent
FI940469A7 (fi) * 1991-08-02 1994-02-01 Pfizer Kinoliinijohdannaisia immunostimulantteina
AU4545201A (en) * 2000-03-13 2001-09-24 American Cyanamid Co Method of treating or inhibiting colonic polyps
US7026484B2 (en) * 2001-02-23 2006-04-11 Ligand Pharmaceuticals Incorporated Tricyclic androgen receptor modulator compounds and methods

Also Published As

Publication number Publication date
EP2035433A1 (en) 2009-03-18
JP2009542584A (ja) 2009-12-03
CA2654234A1 (en) 2007-12-27
US20080108627A1 (en) 2008-05-08
PE20080340A1 (es) 2008-06-25
WO2007147576A1 (en) 2007-12-27
DE102006029445A1 (de) 2007-12-27
TW200808700A (en) 2008-02-16
US7598263B2 (en) 2009-10-06
AR061535A1 (es) 2008-09-03

Similar Documents

Publication Publication Date Title
ECSP109903A (es) Derivados de pirazinona y su uso en el tratamiento de enfermedades pulmonares
UY30846A1 (es) Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos
ECSP055853A (es) Nuevos derivados de fluoroglicosidos heterociclicos, productos farmaceuticos que contienen dichos compuestos, y el uso de los mismos
ECSP109856A (es) Derivados de oxadiazol y su uso como potenciadores de los receptores metabotrópicos de glutamato - 842
SV2009003299A (es) Derivados de dihidropiridina de utilidad como inhibidores de la proteina quinasa
ECSP099750A (es) Imidazoquinolinas con propiedades inmunomoduladoras
CL2008003096A1 (es) Compuestos derivados de piperidino-dihidrotienopirimidinas; inhibidores pde4; composicion farmaceutica que los comprende; y uso en el tratamiento de trastornos o enfermedades de las vias respiratorias o gastrointestinales, como tambien enfermedades inflamatorias de las articulaciones u ojos, entre otras.
DOP2011000176A (es) Compuestos organicos
UY30759A1 (es) Compuestos quimicos
UY31922A (es) Compuestos
CR10356A (es) Derivados de 4-benzilphthalazinona 2-sustituidos como antagonistas de histamina h1 y h3
DOP2009000165A (es) Derivados de oxindol sustituido, medicamentos que los comprenden y uso de los mismos
AR071120A1 (es) Derivados de diosmetina, su procedimiento de preparacion, las composiciones farmaceuticas que los contienen y su uso en el tratamiento de las enfermedades venosas cronicas.
ECSP099442A (es) Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona
CR11684A (es) Dihidropirazolonas sustituidas de hif-propil-4- como inhibidores hidroxilasa
UY30610A1 (es) Moduladores de mglur5
HN2008001393A (es) Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
CR10497A (es) Derivados de piperazinilo utiles en el tratamiento de enfermedades mediadas por el receptor gpr38
UY30215A1 (es) Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones
CR9469A (es) Derivados de urea, metodos para su fabricacion y usos para los mismos
UY29213A1 (es) Derivados de quinolina e isoquinolina 5-sustitiuidos, un procedimiento para su preparación y su uso como inhibidores de la inflamación
BRPI0916571A2 (pt) composto derivado de alquilaminometiloxazolidinona tricíclo, medicamento e composição farmacêutica que o contém e uso do composto
GT200600081A (es) Derivados de acetilenno
UY30424A1 (es) Derivados de quinolina, su preparacion, su uso y medicamentos que comprenden los mismos.
BRPI0820985A2 (pt) Composto derivado de 5-aminociclometil-oxazondin-2-ona, medicamento e composição farmacêutica que os contém e uso dos mesmos

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20170711